• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC DECANAV; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC DECANAV; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING Back to Search Results
Catalog Number R7F282CT
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Cardiac Tamponade (2226)
Date of Event 07/21/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that during idiopathic ventricular tachycardia (idvt) ablation procedure mapping with decanav catheter the patient experienced blood pressure dropped, heart rate increased and effusion treated with pericardiocentesis.During the mapping portion of the case, while using only the decanav for mapping, the patient¿s blood pressure dropped, and the heart rate began to rise.They immediately checked for an effusion, and one was discovered and confirmed using the ultrasound catheter.The medical intervention provided was pericardiocentesis.The patient was reported to be in stable condition.The case continued with the ablation portion.The physician mentioned that the anatomy of the patient was very thin in the rvot, which may be the reason for the event.The case continued and ended successfully.The physician¿s opinion on the cause of this adverse event is that it was related to the procedure.The patient did not require extended hospitalization.No generator/pump malfunction reported.No catheter exchanges occurred during the procedure or transseptal punctures noted.The event occurred before any ablations were performed.No steam pop or cardiac surgery.
 
Additional Manufacturer Narrative
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's ref.# (b)(4).
 
Additional Manufacturer Narrative
On 26-sep-2025, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Additional Manufacturer Narrative
On 1-oct-2025, the device lot number was received.Field d4.Lot has been populated.Device evaluation details: the product was returned to johnson & johnson medtech (j&j) for evaluation.A visual inspection and revision of all features were performed following johnson & johnson medtech procedures.Visual analysis revealed no damage or anomalies on the device.The device features were reviewed.No magnetic, deflection, or electrical issues were found during the product investigation.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.The root cause of the adverse event remains unknown.The physician's opinion on the cause of the adverse event was the procedure.In addition, no device malfunction was reported, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The instruction for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.As part of the johnson & johnson medtech quality process, all devices are manufactured, inspected, and released to approved specifications.With lot number availability, the manufacture date, expiration date and udi have been made available.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DECANAV
Common Device Name
CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
henry boden
31 technology dr
irvine, CA 92618
9497882078
MDR Report Key22800797
Report Number2029046-2025-02684
Device Sequence Number21033967
Product Code DRF
UDI-Device Identifier10846835008807
UDI-Public(01)10846835008807(17)260506(10)31645760M
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K080425
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/06/2026
Device Catalogue NumberR7F282CT
Device Lot Number31645760M
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/21/2025
Supplement Date Received by Manufacturer09/26/2025
10/01/2025
Initial Report FDA Received Date08/13/2025
Supplement Report FDA Received Date09/29/2025
10/23/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/07/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CARTO 3 SYSTEM; NGEN RF GENERATOR, US; UNKNOWN GENERATOR
Outcome Attributed to Adverse Event Life Threatening; Required Intervention;
Patient SexFemale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-